发明名称 |
Combinations of AKT inhibitor compounds and erlotinib, and methods of use |
摘要 |
The invention provides A combination of, a) a compound of Formula (I) or a pharmaceutically acceptable salt thereof; and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer. |
申请公布号 |
AU2012236138(A1) |
申请公布日期 |
2013.11.14 |
申请号 |
AU20120236138 |
申请日期 |
2012.03.30 |
申请人 |
GENENTECH, INC. |
发明人 |
NANNINI, MICHELLE;SAMPATH, DEEPAK |
分类号 |
C07D239/70;A61K31/517;A61P35/00 |
主分类号 |
C07D239/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|